276 related articles for article (PubMed ID: 38172934)
1. Research progress in the management of vascular disease with cannabidiol: a review.
Guo Y; Wei R; Deng J; Guo W
J Cardiothorac Surg; 2024 Jan; 19(1):6. PubMed ID: 38172934
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease.
Kicman A; Toczek M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937917
[TBL] [Abstract][Full Text] [Related]
3. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
Elsaid S; Kloiber S; Le Foll B
Prog Mol Biol Transl Sci; 2019; 167():25-75. PubMed ID: 31601406
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
Aziz AI; Nguyen LC; Oumeslakht L; Bensussan A; Ben Mkaddem S
Cannabis Cannabinoid Res; 2023 Apr; 8(2):254-269. PubMed ID: 36413346
[No Abstract] [Full Text] [Related]
5. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
Romano B; Borrelli F; Pagano E; Cascio MG; Pertwee RG; Izzo AA
Phytomedicine; 2014 Apr; 21(5):631-9. PubMed ID: 24373545
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
Scuderi C; Filippis DD; Iuvone T; Blasio A; Steardo A; Esposito G
Phytother Res; 2009 May; 23(5):597-602. PubMed ID: 18844286
[TBL] [Abstract][Full Text] [Related]
7. Scientific Validation of Cannabidiol for Management of Dog and Cat Diseases.
Corsato Alvarenga I; Panickar KS; Hess H; McGrath S
Annu Rev Anim Biosci; 2023 Feb; 11():227-246. PubMed ID: 36790884
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective potential of cannabidiol: Molecular mechanisms and clinical implications.
Tambe SM; Mali S; Amin PD; Oliveira M
J Integr Med; 2023 May; 21(3):236-244. PubMed ID: 36973157
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.
Durst R; Danenberg H; Gallily R; Mechoulam R; Meir K; Grad E; Beeri R; Pugatsch T; Tarsish E; Lotan C
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3602-7. PubMed ID: 17890433
[TBL] [Abstract][Full Text] [Related]
10. Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.
Crippa JA; Guimarães FS; Campos AC; Zuardi AW
Front Immunol; 2018; 9():2009. PubMed ID: 30298064
[No Abstract] [Full Text] [Related]
11. Biochemical aspects and therapeutic mechanisms of cannabidiol in epilepsy.
Boleti APA; Frihling BEF; E Silva PS; Cardoso PHO; de Moraes LFRN; Rodrigues TAA; Biembengute MEF; Koolen HHF; Migliolo L
Neurosci Biobehav Rev; 2022 Jan; 132():1214-1228. PubMed ID: 33031814
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Analgesic Effect of High-Cannabidiol-Content Cannabis Extracts in Different Pain Models by Using Polymeric Micelles as Vehicles.
Román-Vargas Y; Porras-Arguello JD; Blandón-Naranjo L; Pérez-Pérez LD; Benjumea DM
Molecules; 2023 May; 28(11):. PubMed ID: 37298776
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol, a Regulator of Intracellular Calcium and Calpain.
Jeon KH; Park SH; Bae WJ; Kim SW; Park HJ; Kim S; Kim TH; Jeon SH; Park I; Park HJ; Kwon Y
Cannabis Cannabinoid Res; 2023 Feb; 8(1):119-125. PubMed ID: 35196129
[TBL] [Abstract][Full Text] [Related]
14. Regulation of DNA Methylation by Cannabidiol and Its Implications for Psychiatry: New Insights from In Vivo and In Silico Models.
Domingos LB; Silva NR; Chaves Filho AJM; Sales AJ; Starnawska A; Joca S
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421839
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of the antipsychotic properties of cannabidiol in humans.
Iseger TA; Bossong MG
Schizophr Res; 2015 Mar; 162(1-3):153-61. PubMed ID: 25667194
[TBL] [Abstract][Full Text] [Related]
16. Is Cannabidiol a Promising Substance for New Drug Development? A Review of its Potential Therapeutic Applications.
Noreen N; Muhammad F; Akhtar B; Azam F; Anwar MI
Crit Rev Eukaryot Gene Expr; 2018; 28(1):73-86. PubMed ID: 29773016
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol and substance use disorder: Dream or reality.
Karimi-Haghighi S; Razavi Y; Iezzi D; Scheyer AF; Manzoni O; Haghparast A
Neuropharmacology; 2022 Apr; 207():108948. PubMed ID: 35032495
[TBL] [Abstract][Full Text] [Related]
18. A Novel Standardized
Mabou Tagne A; Marino F; Legnaro M; Luini A; Pacchetti B; Cosentino M
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013912
[TBL] [Abstract][Full Text] [Related]
19. Drug-Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics.
Buchtova T; Lukac D; Skrott Z; Chroma K; Bartek J; Mistrik M
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769206
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action.
Ożarowski M; Karpiński TM; Zielińska A; Souto EB; Wielgus K
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
